Table 1.
Association of LINC01559 expression with clinical features in 96 triple-negative breast cancer patients.
| Parameters | Total (n = 96) | LINC01559 expression |
p value | |
|---|---|---|---|---|
| Low (n = 48) | High (n = 48) | |||
| Age (years) | ||||
| ≤ 40 | 28 | 12 | 16 | 0.369 |
| > 40 | 68 | 36 | 32 | |
| Menopause | ||||
| Yes | 40 | 22 | 18 | 0.408 |
| No | 56 | 26 | 30 | |
| Tumor size (cm) | ||||
| ≤ 2 | 44 | 28 | 16 | 0.014 |
| > 2 | 52 | 20 | 32 | |
| Lymph node metastasis | ||||
| Negative | 36 | 23 | 13 | 0.035 |
| Positive | 60 | 25 | 35 | |
| TNM stage | ||||
| I | 25 | 20 | 5 | <0.001 |
| II | 48 | 24 | 24 | |
| III | 23 | 4 | 19 | |
The statistical method was chi-square test.
The median value of LINC01559 expression was used to divide the high and low LINC01559 groups.
p < 0.05 was indicative of statistical significance (bold font).